336 related articles for article (PubMed ID: 16939715)
1. West Nile virus immunoglobulin A (WNV IgA) detection in cerebrospinal fluid in relation to WNV IgG and IgM reactivity.
Nixon ML; Prince HE
J Clin Virol; 2006 Nov; 37(3):174-8. PubMed ID: 16939715
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin G avidity in differentiation between early and late antibody responses to West Nile virus.
Fox JL; Hazell SL; Tobler LH; Busch MP
Clin Vaccine Immunol; 2006 Jan; 13(1):33-6. PubMed ID: 16425997
[TBL] [Abstract][Full Text] [Related]
3. Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors.
Prince HE; Tobler LH; Lapé-Nixon M; Foster GA; Stramer SL; Busch MP
J Clin Microbiol; 2005 Sep; 43(9):4316-20. PubMed ID: 16145071
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of West Nile virus in central nervous system infections of unknown etiology in Ankara, Turkey].
Ergünay K; Aydoğan S; Menemenlioğlu D; Sener B; Lederer S; Steinhagen K; Hasçelik G; Pinar A; Ozkul A; Us D
Mikrobiyol Bul; 2010 Apr; 44(2):255-62. PubMed ID: 20549960
[TBL] [Abstract][Full Text] [Related]
5. Persistence of West Nile Virus (WNV) IgM antibodies in cerebrospinal fluid from patients with CNS disease.
Kapoor H; Signs K; Somsel P; Downes FP; Clark PA; Massey JP
J Clin Virol; 2004 Dec; 31(4):289-91. PubMed ID: 15494271
[TBL] [Abstract][Full Text] [Related]
6. Persistence of West Nile virus-specific antibodies in viremic blood donors.
Prince HE; Tobler LH; Yeh C; Gefter N; Custer B; Busch MP
Clin Vaccine Immunol; 2007 Sep; 14(9):1228-30. PubMed ID: 17652525
[TBL] [Abstract][Full Text] [Related]
7. Acute West Nile virus neuroinvasive infections: cross-reactivity with dengue virus and tick-borne encephalitis virus.
Papa A; Karabaxoglou D; Kansouzidou A
J Med Virol; 2011 Oct; 83(10):1861-5. PubMed ID: 21837806
[TBL] [Abstract][Full Text] [Related]
8. [The evaluation of serum presence of antibodies reacting with West Nile Fever virus (WNV) antigens among inhabitants from Podlaskie and Swietokrzyskie region].
Kondrusik M; Ferenczi E; Zajkowska J; Pancewicz S; Grygorczuk S; Swierzbińska R; Hermanowska-Szpakowicz T
Przegl Epidemiol; 2007; 61(2):409-16. PubMed ID: 17956061
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a West Nile virus immunoglobulin A capture enzyme-linked immunosorbent assay.
Prince HE; Lapé-Nixon M
Clin Diagn Lab Immunol; 2005 Jan; 12(1):231-3. PubMed ID: 15643014
[TBL] [Abstract][Full Text] [Related]
10. West Nile virus in Canadian blood donors.
Cameron C; Reeves J; Antonishyn N; Tilley P; Alport T; Eurich B; Towns D; Lane D; Saldanha J
Transfusion; 2005 Apr; 45(4):487-91. PubMed ID: 15819667
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a new West Nile Virus lateral-flow rapid IgM assay.
Sambol AR; Hinrichs SH
J Virol Methods; 2009 May; 157(2):223-6. PubMed ID: 19138705
[TBL] [Abstract][Full Text] [Related]
12. Detection of intrathecal IgM, IgG and IgA in a Cuban West Nile virus confirmed case.
Pupo-Antúnez M; Dorta-Contreras AJ; Vazquez Y; González-Hernández M; Noris-García E; Padilla-Docal B; Bu-Coifiu-Fanego R
Arq Neuropsiquiatr; 2008 Sep; 66(3A):572-4. PubMed ID: 18813726
[No Abstract] [Full Text] [Related]
13. Persistence of antibodies to West Nile virus nonstructural protein 5.
Prince HE; Lapé-Nixon M; Yeh C; Tobler LH; Busch MP
J Clin Virol; 2008 Sep; 43(1):102-6. PubMed ID: 18467165
[TBL] [Abstract][Full Text] [Related]
14. Detection of IgG and IgM to West Nile virus. Development of an immunofluorescence assay.
Malan AK; Stipanovich PJ; Martins TB; Hill HR; Litwin CM
Am J Clin Pathol; 2003 Apr; 119(4):508-15. PubMed ID: 12710123
[TBL] [Abstract][Full Text] [Related]
15. Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic.
Tobler LH; Bianco C; Glynn SA; Schreiber GB; Dille BJ; Prince HE; Lanciotti RS; Linnen JM; Gallarda J; Shyamala V; Smith D; Kleinman SH; Busch MP;
Transfusion; 2005 Apr; 45(4):480-6. PubMed ID: 15819666
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of factors associated with positive IgM capture ELISA results in equids with clinical signs compatible with West Nile virus infection: 1,017 cases (2003).
Tanner JM; Traub-Dargatz JL; Hill AE; Van Campen H; Knight AP; Cunningham WE; Salman MD
J Am Vet Med Assoc; 2006 Feb; 228(3):414-21. PubMed ID: 16448369
[TBL] [Abstract][Full Text] [Related]
17. Virus and antibody dynamics in acute west nile virus infection.
Busch MP; Kleinman SH; Tobler LH; Kamel HT; Norris PJ; Walsh I; Matud JL; Prince HE; Lanciotti RS; Wright DJ; Linnen JM; Caglioti S
J Infect Dis; 2008 Oct; 198(7):984-93. PubMed ID: 18729783
[TBL] [Abstract][Full Text] [Related]
18. [Confirmation of West Nile virus seroreactivity in central nervous system infections of unknown etiology from Ankara Province, Central Anatolia, Turkey].
Ergünay K; Özkul A
Mikrobiyol Bul; 2011 Apr; 45(2):381-3. PubMed ID: 21644083
[TBL] [Abstract][Full Text] [Related]
19. Detection of West Nile virus (WNV)-specific immunoglobulin M in a reference laboratory setting during the 2002 WNV season in the United States.
Prince HE; Hogrefe WR
Clin Diagn Lab Immunol; 2003 Sep; 10(5):764-8. PubMed ID: 12965901
[TBL] [Abstract][Full Text] [Related]
20. Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies.
Hogrefe WR; Moore R; Lape-Nixon M; Wagner M; Prince HE
J Clin Microbiol; 2004 Oct; 42(10):4641-8. PubMed ID: 15472323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
